[{"id":"83fb8ec7-113b-40ac-abe0-a62e72250dc3","acronym":"","url":"https://clinicaltrials.gov/study/NCT03423628","created_at":"2021-01-18T16:53:18.718Z","updated_at":"2024-07-02T16:35:02.625Z","phase":"Phase 1","brief_title":"A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer","source_id_and_acronym":"NCT03423628","lead_sponsor":"AstraZeneca","biomarkers":" IDH1","pipe":" | ","alterations":" IDH1 mutation","tags":["IDH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH1 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AZD1390"],"overall_status":"Recruiting","enrollment":" Enrollment 120","initiation":"Initiation: 04/02/2018","start_date":" 04/02/2018","primary_txt":" Primary completion: 04/22/2026","primary_completion_date":" 04/22/2026","study_txt":" Completion: 04/22/2026","study_completion_date":" 04/22/2026","last_update_posted":"2024-05-20"},{"id":"7465627f-9817-4e6b-bf8b-0246b0f330bd","acronym":"","url":"https://clinicaltrials.gov/study/NCT05917145","created_at":"2023-06-23T13:09:33.536Z","updated_at":"2024-07-02T16:35:22.977Z","phase":"Phase 1","brief_title":"Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors","source_id_and_acronym":"NCT05917145","lead_sponsor":"Mayo Clinic","biomarkers":" IDH1 • IDH2","pipe":" | ","alterations":" IDH wild-type","tags":["IDH1 • IDH2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e WSD0628"],"overall_status":"Recruiting","enrollment":" Enrollment 67","initiation":"Initiation: 01/17/2024","start_date":" 01/17/2024","primary_txt":" Primary completion: 02/01/2028","primary_completion_date":" 02/01/2028","study_txt":" Completion: 02/01/2029","study_completion_date":" 02/01/2029","last_update_posted":"2024-01-18"},{"id":"d0a5377a-7334-4be2-ac58-a433c2cd5996","acronym":"","url":"https://clinicaltrials.gov/study/NCT04882917","created_at":"2021-05-12T11:53:31.984Z","updated_at":"2025-02-25T16:16:13.905Z","phase":"Phase 1","brief_title":"First-in-human Study of M4076 in Advanced Solid Tumors (DDRiver Solid Tumors 410)","source_id_and_acronym":"NCT04882917","lead_sponsor":"EMD Serono Research \u0026 Development Institute, Inc.","biomarkers":" CHEK2","pipe":"","alterations":" ","tags":["CHEK2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lartesertib (M4076)"],"overall_status":"Completed","enrollment":" Enrollment 30","initiation":"Initiation: 05/24/2021","start_date":" 05/24/2021","primary_txt":" Primary completion: 03/31/2023","primary_completion_date":" 03/31/2023","study_txt":" Completion: 03/31/2023","study_completion_date":" 03/31/2023","last_update_posted":"2023-07-20"}]